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Background: The current ‘gold standard’ for serotyping pneumococci is the Quellung test. This technique is
laborious and requires a certain level of training to correctly perform. Commercial pneumococcal latex
agglutination serotyping reagents are available, but these are expensive. In-house production of latex agglutination
reagents can be a cost-effective alternative to using commercially available reagents. This paper describes a method
for the production and quality control (QC) of latex reagents, including problem solving recommendations, for
pneumococcal serotyping.
Results: Here we describe a method for the production of latex agglutination reagents based on the passive
adsorption of antibodies to latex particles. Sixty-five latex agglutination reagents were made using the PneuCarriage
Project (PCP) method, of which 35 passed QC. The other 30 reagents failed QC due to auto-agglutination (n=2), no
reactivity with target serotypes (n=8) or cross-reactivity with non-target serotypes (n=20). Dilution of antisera
resulted in a further 27 reagents passing QC. The remaining three reagents passed QC when prepared without
centrifugation and wash steps. Protein estimates indicated that latex reagents that failed QC when prepared using
the PCP method passed when made with antiserum containing ≤ 500 μg/ml of protein. Sixty-one nasopharyngeal
isolates were serotyped with our in-house latex agglutination reagents, with the results showing complete
concordance with the Quellung reaction.
Conclusions: The method described here to produce latex agglutination reagents allows simple and efficient
serotyping of pneumococci and may be applicable to latex agglutination reagents for typing or identification of
other microorganisms. We recommend diluting antisera or removing centrifugation and wash steps for any latex
reagents that fail QC. Our latex reagents are cost-effective, technically undemanding to prepare and remain stable
for long periods of time, making them ideal for use in low-income countries.
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To date, over 90 capsular serotypes of Streptococcus pneu-
moniae (the pneumococcus) have been described [1,2].
Current vaccines target pneumococcal capsular polysac-
charide and protect against serotypes responsible for the
majority of invasive disease [3,4]. However, widespread
vaccination may lead to the replacement of vaccine sero-
types by non-vaccine serotypes [5,6]. Serotyping is an im-
portant tool for evaluating the long-term effectiveness of* Correspondence: catherine.satzke@mcri.edu.au
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reproduction in any medium, provided the orpneumococcal vaccines and providing broader epidemio-
logical information [7]. The ‘gold standard’ pneumococcal
serotyping method is the Quellung reaction [8,9]. This
microscope-based method is labor intensive, requiring
skill and experience to perform and as a result it is usually
conducted in reference laboratories [10,11].
Several alternate phenotypic and genotypic pneumo-
coccal serotyping methods have been developed [10,12].
In low-income settings, the most common method is
latex agglutination [13-15]. Latex agglutination is simple
and rapid to perform, and the results are relatively easy
to interpret. This technology is also used to identify
other microorganisms, including Cryptococcus spp. [16],
Staphylococcus aureus [17] and rotavirus [18].td. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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adsorbing antibodies to polystyrene latex particles. Com-
mercial pneumococcal serotyping latex reagents have been
developed by the Statens Serum Institut (SSI) [14] how-
ever these are expensive and do not differentiate all known
pneumococcal serotypes. Alternatively, in-house reagents
are easy to prepare and use small amounts of antisera,
making them ideal for serotyping in low-income settings.
This paper details a method for the production and quality
control of latex agglutination reagents for pneumococcal
serotyping, including problem solving recommendations.
Methods
Bacterial isolates
Colonizing and invasive pneumococcal isolates were ob-
tained from a number of geographical regions, including
low-income countries. Isolates were identified as S. pneumo-
niae by optochin susceptibility, bile solubility and Phadebact
Pneumococcal test kit (Bactus AB, Huddinge, Sweden).
Serotypes were determined by the Quellung reaction [9].
Isolates were stored in skim milk-tryptone-glucose-glycerol
(STGG) media [19] at −80°C. Immediately prior to testing,
isolates were cultured onto horse blood agar plates and
incubated for 18–24 h in 5% CO2 at 37°C.
Preparation of latex agglutination reagents
Commercially available pneumococcal factor antisera
(Statens Serum Institut, Copenhagen, Denmark) were used
to prepare latex reagents using the following method.
PneuCarriage project (PCP) method
The method of Lafong and Crothers [20] was used with
several modifications, namely: dilution of antisera and
polystyrene latex beads, incorporation of centrifugation
and wash steps, and use of a higher concentration of bovine
serum albumin (BSA). Briefly, the antiserum was diluted
1/40 with glycine buffered saline (GBS; 1 M NaCl, 0.1 M
glycine, pH 8.2). Polystyrene latex beads (0.8 μm, Sigma-
Aldrich, Buchs, Switzerland) were diluted 1/10 in physio-
logical saline. Equal volumes of diluted antiserum and latex
suspension were mixed and incubated at 37°C on a rotating
wheel for 2 h at approximately 0.01 × g. Two rounds of
centrifugation (15 min at 1100 × g), each followed by
washing in GBS, were performed. Equal volumes of GBS
and GBS containing 0.2% BSA (w/v) (pH 8.2) were added
to a final volume of 4 ml. Sodium azide was added to a final
concentration of 1% (w/v) as a preservative. Latex reagents
were stored at 4°C.
Quality control (QC) of latex agglutination reagents
Latex reagents were brought to room temperature. Firstly,
a visual check was conducted to ensure the suspension was
smooth and white. Each reagent was pipetted onto a glass
slide and rotated for one min to ensure auto-agglutinationwas not present. Then, half a 1 μl loop-full of fresh over-
night culture was quickly and thoroughly mixed with 15 μl
of latex reagent. The slide was rotated for one min with
results observed using an indirect light source over a dark
background.
The reagent was tested against a panel of isolates repre-
senting target and non-target serotypes based on the SSI
key to pneumococcal antisera [21]. At least one isolate of
each target and non-target serotype was included in
testing. Where there was only one target or non-target
serotype in the SSI key, two different isolates were tested.
Colonizing isolates were included where possible.
Reagents passed QC if the target serotype reactions dis-
played agglutination and clearing of the suspension, while
non-target serotype reactions remained smooth and white
(Figure 1). Reactions that were stringy, or agglutinated
weakly around the edge of the drop, were considered
negative. QC of latex reagents was performed 12 months
after production and then every 6 months.
Protein assay
BCA protein assays (Pierce Biotechnology, Rockford, USA)
were performed to determine the protein concentration of
the antisera, and were conducted as per the manufacturer’s
instructions.
Results and discussion
Overall, a total of 65 latex agglutination reagents were
made using the PCP method, of which 35 passed QC.
The other 30 reagents failed QC due to auto-agglutination
(n=2), no reactivity with target serotypes (n=8) or cross-
reactivity with non-target serotypes (n=20).
Several experiments were conducted to address the causes
of QC failure for some latex reagents. These included prior
washing of the latex particles to remove interfering surfac-
tant groups [22] and changing the pH and concentrations
of buffer solutions to reduce non-specific agglutination
[14,23]. However, these approaches did not alter the per-
formance of the latex reagents (data not shown).
BCA protein assays were performed to compare the
protein concentrations of antisera in reagents that con-
sistently passed and failed QC (23b and 6b respectively).
The concentration of protein in the antiserum was higher
for the reagent that failed QC (929.7 μg/ml) compared to
the one that passed (207.5 μg/ml). This observation led
us to perform doubling dilutions of antisera ranging from
1/80 to 1/1280 to prepare latex reagents that previously
failed QC (n=30). Diluting the antisera resulted in 27 of
these latex reagents passing QC.
To determine if there was an optimal protein concentra-
tion, BCA protein assays were performed on a number of
antisera. Figure 2 shows all 27 latex reagents that failed QC
when prepared using the PCP method subsequently passed
when made with antiserum containing ≤ 500 μg/ml of
A B
Figure 1 Latex agglutination test. A positive reaction (A) has visible agglutination and clearing, whilst a negative reaction (B) is smooth and white.
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tions below this value are used to prepare latex reagents,
they are more likely to result in a QC pass. Interestingly,
of the 27 latex reagents that failed QC, 19 passed when
made with antiserum containing ≤ 76 μg/ml of protein,
suggesting that further dilution of antiserum may be bene-
ficial. Our results also indicate that protein concentrations
vary between different antisera, and between different lot
numbers of the same antiserum.
Three reagents prepared using the PCP method with
antisera dilutions failed QC (7e, 19b and 28b). These reac-
tions displayed weak agglutination that was not accom-
panied by clearing of the suspension with target serotypes.
Based on the publication by Severin [24] we removed the
centrifugation and wash steps thereby reducing the pos-
sibility of disrupting the bound antibody from the latex
particle and increasing the strength of agglutination and
clearing. To prepare these three reagents we followed
Severin’s method with some modifications, namely, a
different antisera dilution, a 1/10 dilution of polystyrene
latex beads and GBS containing 0.2% BSA. This ap-

































Figure 2 Protein concentration of antisera in latex agglutination
reagents. Each paired data point represents the protein concentration
(μg/ml) of antisera used to prepare latex reagents with the PCP
method that failed or passed quality control (QC) procedures.To assess the accuracy of the latex factor agglutination
reagents post-optimization, serotyping was performed on
61 randomly selected nasopharyngeal isolates from devel-
oping countries, specifically The Gambia (n=1), Fiji (n=12),
Papua New Guinea (n=12), Bangladesh (n=17) and Kenya
(n=19). The isolates were also tested using the Quellung
reaction. Of the 61 isolates, 21 serotypes from 13 ser-
ogroups were identified. These represented serotypes 9V,
15A, 18A, 19B, 22F, 35A and 41A (n=1 of each serotype),
6D, 9N, 10A and 17F (n=2 of each serotype), 6B, 6C, 11A,
16F and 19A (n=3 of each serotype), 35B (n=4), 6A (n=5),
23F (n=6), 15B/C (n=7) and 19F (n=9). Latex agglutin-
ation and Quellung serotyping results were in concord-
ance with each other for all 61 isolates.
Given the importance of these reagents, it would be pru-
dent to QC latex reagents regularly to ensure they remain
stable and reactive. In our laboratory, latex reagents stored
at 2 to 8°C, continued to pass QC for a minimum of two
years (data not shown). Given this, and the current lack of
long-term data, we suggest reagents be retested after an
initial 12 month period, then every 6 months.
The cost of producing our latex factor reagents is
$13.77 USD per bottle (4 ml) and $0.06 USD per test
(15 μl), excluding labor and consumable costs. In our
laboratory it takes approximately 4 h to produce and
QC twelve latex reagents, and the QC consumable costs
are approximately $2.10 USD per bottle. Most reagents
(35/65) passed QC with a single dilution, for the remain-
der the mean number of dilutions required was 3.1 (95%
CI: 2.6, 3.5).
In order to produce in-house latex reagents a collection
of antisera is required. Laboratories that are conducting
Quellung will already have this resource available. Given
that the cost of commercial latex reagents range from
approximately $1.26-1.94 USD per test, and that the cost
of each Quellung test (1 μl) in our laboratory is $0.21
USD, in-house latex reagents may be a cost effective op-
tion for laboratories routinely performing serotyping.
Conclusions
Overall, a total of 65 latex agglutination reagents were pro-
duced and validated for the serotyping of pneumococci.
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tion of antisera for producing latex agglutination reagents.
For reagents that fail QC, two problem solving approaches
should be taken. The first approach is to further dilute the
antisera. If this is unsuccessful, the second approach of re-
moving centrifugation and wash steps should be applied.
Protein estimates may be useful when attempting to make
a latex reagent with a new lot number of antisera, indicat-
ing what dilution to use in order to obtain a reagent that
passes QC.
The method described here to produce latex agglutin-
ation reagents allows simple and efficient serotyping of
pneumococci. Although this paper describes the produc-
tion of reagents using individual factor antisera, we have
successfully created reagents with type and pooled antisera
also (data not shown). Our method may be applicable to
latex reagents for typing or identification of other micro-
organisms. Our latex reagents are cost-effective, tech-
nically undemanding to prepare and remain stable for
long periods of time, making them ideal for use in low-
income countries.
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